AI-Driven Cardiovascular Care Cuts Episodic Visits
Discover how AI-powered specialty care platforms transform patient management, reducing episodic visits and enhancing digital models for continuous care.
Executive Brief
- The News: 60% reduction in hospitalizations achieved by Story Health's platform.
- Clinical Win: 6.9% 30-day HF all-cause readmission rate, less than half the national average.
- Target Specialty: Cardiologists managing heart failure patients with reduced readmissions.
Key Data at a Glance
Acquisition Year: 2020 (Story Health founding year)
Reduction in Hospitalizations: 60%
30-day HF Readmission Rate: 6.9%
Readmission Reduction: Less than half the national average
New Specialty Care Programs: Diabetes and COPD
Story Health Founders: Tom Stanis, Nikhil Roy, Dr. Ashul Govil
AI-Driven Cardiovascular Care Cuts Episodic Visits
What You Should Know:
– Innovaccer Inc., a healthcare AI company, has announced the acquisition of Story Health, a pioneering AI-powered, tech-enabled platform focused on transforming specialty care from episodic to continuous, digital models.
– This marks Innovaccer’s fourth acquisition in the past two years and expands its Healthcare Intelligence Cloud into agentic care augmentation.
Story Health was founded in 2020 by Google veterans Tom Stanis, Nikhil Roy, and Dr. Ashul Govil. The company’s cardiovascular care platform combines AI-driven clinical pathways, advanced medication workflows, and human-led coaching to shift care from episodic visits to continuous digital management.
This strategic acquisition brings Story Health’s founder, Tom Stanis, into Innovaccer’s team and pioneers a new model of AI-augmented specialty care. The partnership pairs Innovaccer’s AI operating system and health system footprint with Story Health’s proven, tech-enabled specialty care model, which has demonstrated significant results:
Reduced hospitalizations by 60%.
Cut readmissions to less than half the national average, with a 6.9% 30-day HF all-cause readmission rate.
Improved access and medication adherence at leading health systems.
Innovaccer’s CEO, Abhinav Shashank, sees this partnership as a major step from just providing “dashboards and insights” to enabling frontline clinical transformation. He believes this will make continuous, AI-assisted specialty care the “new normal”. Tom Stanis, co-founder and CEO of Story Health, added that joining forces will allow them to scale nationally and turn continuous, AI-assisted specialty care into the new normal.
Post-Acquisition Plans
The combined platform will support fully integrated clinical pathways across primary and specialty care, empowering health systems to operate with new levels of scale, speed, and clinical precision. Existing Story Health customers, which include ChristianaCare, Intermountain Health, and Saint Luke’s Health System, will continue to receive uninterrupted service with expanded access to Innovaccer’s broader AI-powered capabilities. Story Health will also continue its commitment to continuous care across other specialties and will be launching programs for diabetes and COPD. The company’s goal is to scale this model, empowering teams to provide continuous, personalized care without adding to the clinician burden.
Clinical Perspective — Dr. Aarti Ghosh, Immunology
Workflow: With the acquisition of Story Health, I'll be able to leverage AI-powered clinical pathways to streamline my specialty care workflow. The combination of Innovaccer's AI operating system and Story Health's tech-enabled specialty care model will enable me to provide continuous, digital management to my patients. This will likely reduce the time I spend on episodic visits, allowing me to focus on more complex cases.
Economics: The article doesn't address cost directly, but the reduced hospitalizations by 60% and cut readmissions to less than half the national average will likely have a significant economic impact. With a 6.9% 30-day HF all-cause readmission rate, the cost savings from reduced readmissions will be substantial. However, the exact economic benefits will depend on various factors, including the specific health system and patient population.
Patient Outcomes: The acquisition of Story Health is expected to improve patient outcomes, with reduced hospitalizations by 60% and a 6.9% 30-day HF all-cause readmission rate. The improved access and medication adherence will also lead to better health outcomes for patients. Additionally, the expansion of continuous, AI-assisted specialty care to other specialties, such as diabetes and COPD, will further enhance patient care and outcomes.
Transparency & Corrections
HCP Connect is funded by Stravent LLC and maintains editorial independence from advertisers and pharmaceutical companies. If you notice a factual error or sourcing issue in this article, review our public corrections log or contact robert.foster@straventgroup.com.